v3.21.2
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Balance at Dec. 31, 2019 $ 142,361 $ 4 $ 0 $ 271,182 $ (128,822) $ (3)
Balance (in shares) at Dec. 31, 2019   16,723,128 0      
Increase (Decrease) in Stockholders' Equity            
Net loss (4,945)       (4,945)  
Other comprehensive income (1,358)         (1,358)
Stock option exercise 688     688    
Stock option exercise (in shares)   22,208        
Restricted stock 958     958    
Restricted stock (in shares)   105,710        
Consideration for acquisition 1,750     1,750    
Consideration for acquisition (in shares)   36,628        
Repurchase of common stock (187)   $ (187)      
Repurchase of common stock (in shares)     (4,014)      
Balance at Mar. 31, 2020 139,267 $ 4 $ (187) 274,578 (133,767) (1,361)
Balance (in shares) at Mar. 31, 2020   16,887,674 (4,014)      
Balance at Dec. 31, 2019 142,361 $ 4 $ 0 271,182 (128,822) (3)
Balance (in shares) at Dec. 31, 2019   16,723,128 0      
Increase (Decrease) in Stockholders' Equity            
Net loss (18,931)          
Other comprehensive income 70          
Balance at Sep. 30, 2020 239,436 $ 5 $ 0 387,117 (147,753) 67
Balance (in shares) at Sep. 30, 2020   19,554,621 0      
Balance at Mar. 31, 2020 139,267 $ 4 $ (187) 274,578 (133,767) (1,361)
Balance (in shares) at Mar. 31, 2020   16,887,674 (4,014)      
Increase (Decrease) in Stockholders' Equity            
Net loss (9,447)       (9,447)  
Other comprehensive income 1,522         1,522
Stock option exercise 593     593    
Stock option exercise (in shares)   19,162        
Restricted stock 2,495     2,495    
Restricted stock (in shares)   52,032        
Consideration for acquisition 37,638     37,638    
Consideration for acquisition (in shares)   989,154        
Issuance of common stock, net of issuance cost 70,394 $ 1 $ 187 70,206    
Issuance of common stock, net of issuance cost (in shares)   1,595,986 4,014      
Balance at Jun. 30, 2020 242,462 $ 5 $ 0 385,510 (143,214) 161
Balance (in shares) at Jun. 30, 2020   19,544,008 0      
Increase (Decrease) in Stockholders' Equity            
Net loss (4,539)       (4,539)  
Other comprehensive income (94)         (94)
Stock option exercise 348     348    
Stock option exercise (in shares)   11,230        
Restricted stock 1,259     1,259    
Restricted stock (in shares)   (617)        
Balance at Sep. 30, 2020 239,436 $ 5 $ 0 387,117 (147,753) 67
Balance (in shares) at Sep. 30, 2020   19,554,621 0      
Balance at Dec. 31, 2020 $ 234,768 $ 5   388,622 (161,766) 7,907
Balance (in shares) at Dec. 31, 2020 19,560,291 19,560,291        
Increase (Decrease) in Stockholders' Equity            
Net loss $ (10,379)       (10,379)  
Other comprehensive income (3,622)         (3,622)
Stock option exercise 62     62    
Stock option exercise (in shares)   2,010        
Restricted stock 1,316     1,316    
Restricted stock (in shares)   97,111        
Balance at Mar. 31, 2021 222,145 $ 5   390,000 (172,145) 4,285
Balance (in shares) at Mar. 31, 2021   19,659,412        
Balance at Dec. 31, 2020 $ 234,768 $ 5   388,622 (161,766) 7,907
Balance (in shares) at Dec. 31, 2020 19,560,291 19,560,291        
Increase (Decrease) in Stockholders' Equity            
Net loss $ (16,332)          
Other comprehensive income (1,625)          
Balance at Sep. 30, 2021 $ 221,118 $ 5   392,929 (178,098) 6,282
Balance (in shares) at Sep. 30, 2021 19,672,162 19,672,162        
Balance at Mar. 31, 2021 $ 222,145 $ 5   390,000 (172,145) 4,285
Balance (in shares) at Mar. 31, 2021   19,659,412        
Increase (Decrease) in Stockholders' Equity            
Net loss (3,756)       (3,756)  
Other comprehensive income 1,797         1,797
Restricted stock 1,415     1,415    
Restricted stock (in shares)   10,632        
Balance at Jun. 30, 2021 221,601 $ 5   391,415 (175,901) 6,082
Balance (in shares) at Jun. 30, 2021   19,670,044        
Increase (Decrease) in Stockholders' Equity            
Net loss (2,197)       (2,197)  
Other comprehensive income 200         200
Stock option exercise 75     75    
Stock option exercise (in shares)   2,412        
Restricted stock 1,439     1,439    
Restricted stock (in shares)   (294)        
Balance at Sep. 30, 2021 $ 221,118 $ 5   $ 392,929 $ (178,098) $ 6,282
Balance (in shares) at Sep. 30, 2021 19,672,162 19,672,162